Docetaxel for Castration-sensitive Prostate Cancer: Wrapping up Unfinished Business?
University of Alabama at Birmingham (UAB) Comprehensive Cancer Center, Birmingham, AL, USA.
Guru
G
Sonpavde
Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA; University Hospital del Mar-IMIM, Barcelona, Spain. Electronic address: joaquim_bellmunt@dfci.harvard.edu.
Joaquim
J
Bellmunt
D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009919:Orchiectomy; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy
D000970:Antineoplastic Agents